GEP20207073B - Polyonic infusion solution - Google Patents
Polyonic infusion solutionInfo
- Publication number
- GEP20207073B GEP20207073B GEAP201814899A GEAP2018014899A GEP20207073B GE P20207073 B GEP20207073 B GE P20207073B GE AP201814899 A GEAP201814899 A GE AP201814899A GE AP2018014899 A GEAP2018014899 A GE AP2018014899A GE P20207073 B GEP20207073 B GE P20207073B
- Authority
- GE
- Georgia
- Prior art keywords
- polyonic
- infusion solution
- potassium
- water
- sodium
- Prior art date
Links
- 239000003978 infusion fluid Substances 0.000 title 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical class [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 abstract 1
- AEKLPNAELPOQBI-RHLRHBBGSA-L disodium butanedioate (2R,3R,4R,5S)-6-(methylamino)hexane-1,2,3,4,5-pentol Chemical compound [Na+].C(CCC(=O)[O-])(=O)[O-].CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.[Na+] AEKLPNAELPOQBI-RHLRHBBGSA-L 0.000 abstract 1
- 235000011147 magnesium chloride Nutrition 0.000 abstract 1
- 239000011591 potassium Substances 0.000 abstract 1
- 229910052700 potassium Inorganic materials 0.000 abstract 1
- 235000011164 potassium chloride Nutrition 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 235000002639 sodium chloride Nutrition 0.000 abstract 1
- 239000003381 stabilizer Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/194—Carboxylic acids, e.g. valproic acid having two or more carboxyl groups, e.g. succinic, maleic or phthalic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/14—Alkali metal chlorides; Alkaline earth metal chlorides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
A solution contains sodium, potassium and magnesium chlorides, meglumine sodium succinate, stabilizing agent and water.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2017135900A RU2676761C1 (en) | 2017-10-09 | 2017-10-09 | Polyionic infusion solution |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| GEAP201914899A GEAP201914899A (en) | 2019-10-10 |
| GEP20207073B true GEP20207073B (en) | 2020-02-25 |
Family
ID=65024999
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GEAP201814899A GEP20207073B (en) | 2017-10-09 | 2018-10-09 | Polyonic infusion solution |
Country Status (11)
| Country | Link |
|---|---|
| CN (1) | CN111372573B (en) |
| BR (1) | BR112020006585A2 (en) |
| CL (1) | CL2020000971A1 (en) |
| CO (1) | CO2020005293A2 (en) |
| EA (1) | EA035241B1 (en) |
| GE (1) | GEP20207073B (en) |
| MY (1) | MY201837A (en) |
| PH (1) | PH12020550196A1 (en) |
| RU (1) | RU2676761C1 (en) |
| UA (1) | UA146728U (en) |
| WO (1) | WO2019074404A1 (en) |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5366730A (en) * | 1989-12-20 | 1994-11-22 | Boehringer Mannheim Gmbh | Stabilized compositions having human tissue type plasminogen activator enzymatic activity |
| EA000879B1 (en) * | 1998-12-02 | 2000-06-26 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Infusion solution ''reamberin'' |
| RU2240116C1 (en) * | 2003-08-20 | 2004-11-20 | Общество С Ограниченной Ответственностью "Научно-Технологическая Фармацевтическая Фирма "Полисан" | Disintoxicating infusion solution |
| SE0401842D0 (en) * | 2004-07-12 | 2004-07-12 | Dizlin Medical Design Ab | Infusion and injection solution of levodopa |
| CN102600070B (en) * | 2011-12-22 | 2014-08-27 | 湖北德康药业有限公司 | Meglumine adenosine cyclophosphate composition injection and preparation method thereof |
| RU2536994C1 (en) * | 2013-05-17 | 2014-12-27 | Общество С Ограниченной Ответственностью "Нпо "Нефрон" | Concentrated acidic component, kit for producing it, concentrated solution of acidic component for producing hemodialysis solution and method for producing it |
| RU2549448C1 (en) * | 2014-05-20 | 2015-04-27 | Екофарм Патент Менеджмент Аг | Balanced infusion solution |
| CN104224829A (en) * | 2014-09-23 | 2014-12-24 | 四川科伦药业股份有限公司 | Injection containing sodium, potassium, magnesium, calcium and glucose injection and preparation method of injection |
| CN105213329B (en) * | 2015-11-10 | 2018-03-27 | 瑞阳制药有限公司 | Meglumine cyclic adenosine for injecta freeze-dried powder and preparation method thereof |
-
2017
- 2017-10-09 RU RU2017135900A patent/RU2676761C1/en active
-
2018
- 2018-02-20 EA EA201800110A patent/EA035241B1/en unknown
- 2018-10-04 MY MYPI2020001143A patent/MY201837A/en unknown
- 2018-10-04 WO PCT/RU2018/050119 patent/WO2019074404A1/en active Application Filing
- 2018-10-04 CN CN201880075843.4A patent/CN111372573B/en active Active
- 2018-10-04 BR BR112020006585-4A patent/BR112020006585A2/en unknown
- 2018-10-08 UA UAA201810017U patent/UA146728U/en unknown
- 2018-10-09 GE GEAP201814899A patent/GEP20207073B/en unknown
-
2020
- 2020-04-01 PH PH12020550196A patent/PH12020550196A1/en unknown
- 2020-04-09 CL CL2020000971A patent/CL2020000971A1/en unknown
- 2020-04-28 CO CONC2020/0005293A patent/CO2020005293A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EA201800110A1 (en) | 2019-04-30 |
| BR112020006585A2 (en) | 2020-10-06 |
| CN111372573B (en) | 2022-04-29 |
| RU2676761C1 (en) | 2019-01-11 |
| PH12020550196A1 (en) | 2021-03-01 |
| MY201837A (en) | 2024-03-19 |
| CL2020000971A1 (en) | 2020-08-21 |
| UA146728U (en) | 2021-03-17 |
| GEAP201914899A (en) | 2019-10-10 |
| CN111372573A (en) | 2020-07-03 |
| EA035241B1 (en) | 2020-05-20 |
| CO2020005293A2 (en) | 2020-05-29 |
| WO2019074404A1 (en) | 2019-04-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018008128A (en) | Persistent conjugate of triple activator activating glucagon, glp-1 and gip receptor. | |
| HK1243500A1 (en) | Drum unit, cartridge and coupling member | |
| MX2016009858A (en) | Anti-pcsk9~glp-1 fusions and methods for use. | |
| MX2019008546A (en) | Therapeutic uses of an insect powder. | |
| MX2020003514A (en) | A salt recovery solution and processes of use thereof. | |
| MX2021010886A (en) | Medicaments for slowing parkinson's disease. | |
| EP3592824A4 (en) | Intradialytic use of sodium thiosulfate | |
| GEP20207073B (en) | Polyonic infusion solution | |
| MX2020004272A (en) | A cartridge configured to form a part of a teatcup, and a teatcup. | |
| GB2543709A (en) | Pharmaceutical agent | |
| EP3684196A4 (en) | Low sodium salt substitute with potassium chloride | |
| MD4410C1 (en) | Balanced infusion solution | |
| AU201715830S (en) | T-Shirt | |
| MX2018001658A (en) | Tumor therapeutic agent. | |
| TWD180197S (en) | Fryer | |
| TWD176499S (en) | Fire equipment connectors | |
| AU201615592S (en) | Alu sofa of one seater | |
| UA81785U (en) | Composition for making hams with blood plasma | |
| TWD183933S (en) | Eye energizer | |
| GB201702889D0 (en) | Mobile software safety application, to create meetings | |
| UA92827U (en) | Virological culture medium " selenohydrolyzyn " | |
| UA93023U (en) | 2- (3-hlorotetrahidrofuran -2-yl) -4- tosyl -5- (trifluoromethyl) -2n-1,2,3-triazole | |
| AU366479S (en) | Laptop case | |
| TWD179543S (en) | Shoe | |
| TWD173957S (en) | massage chair |